536456 — R J Biotech Cashflow Statement
0.000.00%
Consumer DefensivesBalancedMicro Cap
Annual cashflow statement for R J Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -119 | -115 | -42.5 | -157 | -40.5 |
Depreciation | |||||
Non-Cash Items | -39.7 | 48.9 | 15.8 | 43.3 | 8.57 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 129 | 73.3 | 32.8 | 132 | -15.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -26.9 | 8.38 | 7.06 | 19.6 | -47.2 |
Capital Expenditures | -1.18 | -0.675 | -0.659 | -1.15 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -7 | -7.01 | -6.01 | -2.53 | 0 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -8.19 | -7.68 | -6.67 | -3.68 | 0 |
Financing Cash Flow Items | -38.9 | -41.4 | -7.85 | -0.023 | -58.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 34.5 | -0.31 | -0.633 | -15.4 | 46.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.541 | 0.39 | -0.247 | 0.537 | -0.391 |